- Companies
- Accelerant
Accelerant Revenue, Valuation, Funding & Investors
Accelerant is valued at $2.4B as of November 2021, a 2.6x multiple on its last reported $913M revenue.
Last Accelerant valuation
$2.4B
Seed · Nov 2021
Last Accelerant funding round
$18M
Series A · Sep 2024
Accelerant revenue
$913M
Seed · Nov 2021
About Accelerant
Accelerant is a cannabis manufacturing company based in Oakland, California, producing automated pre-roll filling machines for dispensaries and brands. Its Accelerant PRO system outputs up to 1,200 pre-rolls per hour with precise 0.3-gram fills and integrated twisting mechanisms. Offered as Production as a Service, the model includes on-site maintenance and scales pricing per unit produced, serving processors in California and Colorado compliant with state packaging regulations.
Founded
2019
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Usage-based
Revenue
$913M (Nov 2021)
Valuation
$2.4B (Nov 2021)
Accelerant Valuation
Accelerant is currently valued at $2.4B, based on its seed round in November 2021.
Accelerant valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Nov 2021 | Seed | $2.4B | 2.6x |
Accelerant Revenue
Accelerant's latest recorded revenue is $913M, as of its seed round in November 2021. At a $2.4B valuation, that implies a 2.6x revenue multiple.
Accelerant revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Nov 2021 | $913M | $2.4B | 2.6x | Seed |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Accelerant Funding History
Accelerant has raised a total of $24M across 2 funding rounds.
Accelerant's first fundraising round was a $6M seed round in November 2021. The most recent completed round was a $18M Series A in September 2024.
Accelerant funding rounds
| Date | Stage | Raised | Valuation | Deal Summary |
|---|---|---|---|---|
| Sep 2024 | Series A | $18M | - | No information on a VC funding round for Accelerant around September 13, 2024. The closest prior event was a $150 million private equity round on June 22, 2023, led by Eldridge Industries and Barings, with no valuation specified beyond prior unicorn status in 2022. Accelerant is an insurtech platform providing a data-driven risk exchange connecting specialty insurance underwriters with capital partners, headquartered in Atlanta and founded in 2018. Instead, sources detail Accelerant's IPO in July 2025, raising $724 million at a $4.7 billion diluted market value (priced at $21/share) or $6.4 billion valuation (at open $28.50/share), listing on NYSE as ARX. The IPO involved 34.5 million shares, mostly from selling shareholders, to fund platform expansion and global growth in specialty insurance. Post-IPO financials show strong growth: Q3 2025 revenues of $267.4 million (up from $153.7 million YoY), Exchange Written Premium $1.043 billion (17% YoY growth), Adjusted EBITDA $105 million (302% YoY). Full-year 2025 revenue reached $913 million (51% growth from 2024's $603 million), Exchange Written Premium $4.19 billion, Adjusted EBITDA $282 million, though with a $1.35 billion net loss from non-cash IPO-related charges. Gross loss ratios stable at 51-54%. No revenue, ARR, EBITDA, or multiples tied to a 2024 VC round; metrics are IPO-era or later. Platform had 232 members and 96 risk capital partners as of March 2025, with 217% CAGR in Exchange Written Premium since inception. |
| Nov 2021 | Seed | $6M | $2.4B | Accelerant is an insurtech platform acting as a bridge between underwriters and capacity providers in the specialty insurance market. The company secured $150 million in funding led by Barings LLC around late 2021, achieving a post-money valuation of $2.4 billion. This followed a prior raise of approximately $190 million at a $2 billion pre-money valuation. Alongside the funding, Accelerant launched its Risk Exchange platform, providing specialty underwriters with access to risk capital from institutional investors and insurance companies, plus underwriting and portfolio management tools. CEO Jeff Radke emphasized the platform's data transparency, analytics, and long-term capacity solutions to support diverse market opportunities. The funding and product launch underscored Accelerant's innovation in insurance, positioning it for expanded operations and stronger market presence. |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAccelerant Competitors
Accelerant competitors include listed companies like Trulieve Cannabis, Curaleaf, Green Thumb Industries and Cronos Group, and private ones like PAX Labs and Dutchie.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $1.2B | $314M | $2.2B | 2.4x | ||
| Publicly listed | $1.3B | $238M | $2.7B | 2.7x | ||
| Private | $113M | - | $1.7B | 15.0x | ||
| Publicly listed | $1.2B | $469M | $1.6B | 1.6x | ||
| Private | $45M | - | $3.8B | 83.3x | ||
| Publicly listed | $147M | ($43M) | $1.2B | 2.6x |
Accelerant Public Comps
Accelerant is still privately-owned, but its public comps include Beijing Geekplus Tech, AEM, Trulieve Cannabis, Leadshine, Beijing Dahao Technology, Kardex Holding, Alarm.com, Curaleaf, ATS and SIASUN.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $473M | ($930K) | 4.0x | 3.3x | (2027.2x) | 200.6x | |||
| $313M | $37M | 7.1x | 4.9x | 61.1x | 28.1x | |||
| $1.2B | $314M | 2.1x | 2.4x | 7.9x | 6.7x | |||
| $279M | $45M | 8.8x | 6.7x | 55.5x | 40.2x | |||
| $448M | $138M | 4.9x | - | 15.8x | - | |||
| $979M | $83M | 2.1x | 1.9x | 24.5x | 16.4x | |||
| $1B | $184M | 2.8x | 2.6x | 15.2x | 12.9x | |||
| $1.3B | $238M | 2.8x | 2.7x | 14.9x | 12.6x | |||
This data is available for Pro users. Sign up to see all Accelerant competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Accelerant
| When was Accelerant founded? | Accelerant was founded in 2019. |
| Where is Accelerant headquartered? | Accelerant is headquartered in Baltimore, MD, United States. |
| Is Accelerant publicly listed? | No, Accelerant is a private company. |
| What is Accelerant's valuation? | Accelerant was last valued at $2.4B in its seed round in November 2021. |
| How much funding has Accelerant raised? | Accelerant has raised $24M across 2 funding rounds. |
| What was Accelerant's last funding round? | Accelerant's last funding round was a $18M Series A in September 2024. |
| What is Accelerant's revenue? | Accelerant's latest recorded revenue is $913M (November 2021). |
| What is Accelerant's revenue multiple? | Accelerant's latest valuation implies a 2.6x revenue multiple ($2.4B valuation on $913M of revenue). |
| Which companies are comparable to Accelerant? | Companies comparable to Accelerant include Trulieve Cannabis, Curaleaf, PAX Labs, Green Thumb Industries, Dutchie and Cronos Group. |
See companies similar to Accelerant
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




